BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11197591)

  • 1. Efficacy of colony-stimulating factors in acute leukemia.
    Holdsworth MT; Mathew P
    Ann Pharmacother; 2001 Jan; 35(1):92-108. PubMed ID: 11197591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.
    J Clin Oncol; 1994 Nov; 12(11):2471-508. PubMed ID: 7964965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
    Bennett CL; Stinson TJ; Laver JH; Bishop MR; Godwin JE; Tallman MS
    Leuk Lymphoma; 2000 Mar; 37(1-2):65-70. PubMed ID: 10721770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D;
    Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials.
    Wittman B; Horan J; Lyman GH
    Cancer Treat Rev; 2006 Jun; 32(4):289-303. PubMed ID: 16678350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.
    Sasse EC; Sasse AD; Brandalise S; Clark OA; Richards S
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004139. PubMed ID: 16034921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
    Ottmann OG; Bug G; Krauter J
    Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
    Geller RB
    J Clin Oncol; 1996 Apr; 14(4):1371-82. PubMed ID: 8648396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.
    Gurion R; Belnik-Plitman Y; Gafter-Gvili A; Paul M; Vidal L; Ben-Bassat I; Shpilberg O; Raanani P
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008238. PubMed ID: 21901718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
    Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia.
    Ohno R
    Leuk Res; 1998 Dec; 22(12):1143-54. PubMed ID: 9922078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques.
    Harousseau JL; Witz B; Lioure B; Hunault-Berger M; Desablens B; Delain M; Guilhot F; Le Prise PY; Abgrall JF; Deconinck E; Guyotat D; Vilque JP; Casassus P; Tournilhac O; Audhuy B; Solary E
    J Clin Oncol; 2000 Feb; 18(4):780-7. PubMed ID: 10673519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
    Johnston EM; Crawford J
    Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J; Bramwell V; Stephenson B
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
    Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
    N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
    Löwenberg B; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Vellenga E; Ossenkoppele GJ; Huijgens PC; Verdonck LF; van der Lelie J; Wielenga JJ; Schouten HC; Gmür J; Gratwohl A; Hess U; Fey MF; van Putten WL
    J Clin Oncol; 1997 Dec; 15(12):3496-506. PubMed ID: 9396403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.
    Clark OA; Lyman GH; Castro AA; Clark LG; Djulbegovic B
    J Clin Oncol; 2005 Jun; 23(18):4198-214. PubMed ID: 15961767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.